187 related articles for article (PubMed ID: 32475985)
1. The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Grebe TA; Khushf G; Chen M; Bailey D; Brenman LM; Williams MS; Seaver LH;
Genet Med; 2020 Sep; 22(9):1431-1436. PubMed ID: 32475985
[No Abstract] [Full Text] [Related]
2. Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).
Seaver LH; Khushf G; King NMP; Matalon DR; Sanghavi K; Vatta M; Wees K;
Genet Med; 2022 Mar; 24(3):512-520. PubMed ID: 35253645
[No Abstract] [Full Text] [Related]
3. The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Tayeh MK; Chen M; Fullerton SM; Gonzales PR; Huang SJ; Massingham LJ; O'Daniel JM; Stewart DR; Stiles AR; Evans BJ;
Genet Med; 2023 Mar; 25(3):100342. PubMed ID: 36547466
[No Abstract] [Full Text] [Related]
4. Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Best RG; Khushf G; Rabin-Havt SS; Clayton EW; Grebe TA; Hagenkord J; Topper S; Fivecoat J; Chen M; Grody WW;
Genet Med; 2022 Mar; 24(3):509-511. PubMed ID: 35253644
[No Abstract] [Full Text] [Related]
5. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
David KL; Best RG; Brenman LM; Bush L; Deignan JL; Flannery D; Hoffman JD; Holm I; Miller DT; O'Leary J; Pyeritz RE;
Genet Med; 2019 Apr; 21(4):769-771. PubMed ID: 30578420
[No Abstract] [Full Text] [Related]
6. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN;
Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022
[No Abstract] [Full Text] [Related]
7. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG).
Del Gaudio D; Shinawi M; Astbury C; Tayeh MK; Deak KL; Raca G;
Genet Med; 2020 Jul; 22(7):1133-1141. PubMed ID: 32296163
[No Abstract] [Full Text] [Related]
8. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
[No Abstract] [Full Text] [Related]
9. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chung WK; Kearney HM; Monaghan KG; Rehder CW; Chao EC;
Genet Med; 2019 Jun; 21(6):1267-1270. PubMed ID: 31015575
[No Abstract] [Full Text] [Related]
10. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M;
Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144
[No Abstract] [Full Text] [Related]
11. Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Grebe TA; Khushf G; Greally JM; Turley P; Foyouzi N; Rabin-Havt S; Berkman BE; Pope K; Vatta M; Kaur S;
Genet Med; 2024 Apr; 26(4):101052. PubMed ID: 38393332
[No Abstract] [Full Text] [Related]
12. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
[No Abstract] [Full Text] [Related]
13. Considerations for policymakers for improving health care through telegenetics: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Williams HE; Aiyar L; Dinulos MB; Flannery D; McClure ML; Lloyd-Puryear MA; Sanghavi K; Trotter TL; Viskochil D;
Genet Med; 2022 Nov; 24(11):2211-2219. PubMed ID: 36040445
[No Abstract] [Full Text] [Related]
14. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).
Bean LJH; Scheuner MT; Murray MF; Biesecker LG; Green RC; Monaghan KG; Palomaki GE; Sharp RR; Trotter TL; Watson MS; Powell CM;
Genet Med; 2021 Jun; 23(6):979-988. PubMed ID: 33790423
[No Abstract] [Full Text] [Related]
15. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).
Murray MF; Giovanni MA; Doyle DL; Harrison SM; Lyon E; Manickam K; Monaghan KG; Rasmussen SA; Scheuner MT; Palomaki GE; Watson MS;
Genet Med; 2021 Jun; 23(6):989-995. PubMed ID: 33727704
[No Abstract] [Full Text] [Related]
16. The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Abu-El-Haija A; Reddi HV; Wand H; Rose NC; Mori M; Qian E; Murray MF;
Genet Med; 2023 May; 25(5):100803. PubMed ID: 36920474
[No Abstract] [Full Text] [Related]
17. Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Peña LDM; Burrage LC; Enns GM; Esplin ED; Harding C; Mendell JR; Niu ZN; Scharfe C; Yu T; Koeberl DD;
Genet Med; 2023 Jun; 25(6):100831. PubMed ID: 37031408
[No Abstract] [Full Text] [Related]
18. Laboratory perspectives in the development of polygenic risk scores for disease: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Reddi HV; Wand H; Funke B; Zimmermann MT; Lebo MS; Qian E; Shirts BH; Zou YS; Zhang BM; Rose NC; Abu-El-Haija A;
Genet Med; 2023 May; 25(5):100804. PubMed ID: 36971772
[No Abstract] [Full Text] [Related]
19. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
[No Abstract] [Full Text] [Related]
20. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG).
Pal T; Agnese D; Daly M; La Spada A; Litton J; Wick M; Klugman S; Esplin ED; Jarvik GP;
Genet Med; 2020 Apr; 22(4):681-685. PubMed ID: 31831881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
